Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 1
2000 2
2002 1
2003 1
2004 5
2005 5
2006 6
2007 7
2008 2
2009 8
2010 11
2011 17
2012 14
2013 9
2014 15
2015 8
2016 12
2017 14
2018 12
2019 8
2020 17
2021 26
2022 25
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.
Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A, Wählby Hamrén U, Mankad VS, Ren P, Takas T, Abram ME, Leach A, Griffin MP, Villafana T; MELODY Study Group. Hammitt LL, et al. N Engl J Med. 2022 Mar 3;386(9):837-846. doi: 10.1056/NEJMoa2110275. N Engl J Med. 2022. PMID: 35235726 Clinical Trial.
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
Domachowske J, Madhi SA, Simões EAF, Atanasova V, Cabañas F, Furuno K, Garcia-Garcia ML, Grantina I, Nguyen KA, Brooks D, Chang Y, Leach A, Takas T, Yuan Y, Griffin MP, Mankad VS, Villafana T; MEDLEY Study Group. Domachowske J, et al. N Engl J Med. 2022 Mar 3;386(9):892-894. doi: 10.1056/NEJMc2112186. N Engl J Med. 2022. PMID: 35235733 Clinical Trial. No abstract available.
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.
Griffin MP, Yuan Y, Takas T, Domachowske JB, Madhi SA, Manzoni P, Simões EAF, Esser MT, Khan AA, Dubovsky F, Villafana T, DeVincenzo JP; Nirsevimab Study Group. Griffin MP, et al. N Engl J Med. 2020 Jul 30;383(5):415-425. doi: 10.1056/NEJMoa1913556. N Engl J Med. 2020. PMID: 32726528 Clinical Trial.
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
Muller WJ, Madhi SA, Seoane Nuñez B, Baca Cots M, Bosheva M, Dagan R, Hammitt LL, Llapur CJ, Novoa JM, Saez Llorens X, Grenham A, Kelly EJ, Mankad VS, Shroff M, Takas T, Leach A, Villafana T; MELODY Study Group. Muller WJ, et al. N Engl J Med. 2023 Apr 20;388(16):1533-1534. doi: 10.1056/NEJMc2214773. Epub 2023 Apr 5. N Engl J Med. 2023. PMID: 37018470 No abstract available.
Skin Care for the Extremely Low-Birthweight Infant.
Visscher MO, McKeown K, Nurre M, Strange R, Mahan T, Kinnett M, Campbell D, Baker RB, Narendran V. Visscher MO, et al. Among authors: narendran v. Neoreviews. 2023 Apr 1;24(4):e229-e242. doi: 10.1542/neo.24-4-e229. Neoreviews. 2023. PMID: 37002398 Review.
The Slitscope.
Chandrakanth P, Akkara JD, Joshi SM, Gosalia H, Chandrakanth KS, Narendran V. Chandrakanth P, et al. Among authors: narendran v. Indian J Ophthalmol. 2024 May 1;72(5):741-744. doi: 10.4103/IJO.IJO_1589_23. Epub 2024 Jan 8. Indian J Ophthalmol. 2024. PMID: 38189430 Free article.
Correspondence.
Shah PK, Ranjan R, Prema S, Das A, Narendran V. Shah PK, et al. Among authors: narendran v. Retina. 2022 Aug 1;42(8):e34. doi: 10.1097/IAE.0000000000003074. Retina. 2022. PMID: 33315826 No abstract available.
Telemedicine for ROP.
Shah PK, Ramya A, Narendran V. Shah PK, et al. Among authors: narendran v. Asia Pac J Ophthalmol (Phila). 2018 Jan-Feb;7(1):52-55. doi: 10.22608/APO.2017478. Epub 2017 Jan 26. Asia Pac J Ophthalmol (Phila). 2018. PMID: 29405045 Free article. Review.
The Ontogeny of Skin.
Visscher M, Narendran V. Visscher M, et al. Among authors: narendran v. Adv Wound Care (New Rochelle). 2014 Apr 1;3(4):291-303. doi: 10.1089/wound.2013.0467. Adv Wound Care (New Rochelle). 2014. PMID: 24761361 Free PMC article. Review.
Central serous chorioretinopathy: Current update on management.
Manayath GJ, Ranjan R, Karandikar SS, Shah VS, Saravanan VR, Narendran V. Manayath GJ, et al. Among authors: narendran v. Oman J Ophthalmol. 2018 Sep-Dec;11(3):200-206. doi: 10.4103/ojo.OJO_29_2018. Oman J Ophthalmol. 2018. PMID: 30505108 Free PMC article. Review.
217 results